Legal Representation
Attorney
Charles W. Hanor, P.C.
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 21, 2001 | REIN | O | REINSTATED | Loading... |
| Aug 29, 2000 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 29, 2000 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 24, 2000 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 24, 2000 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Dec 28, 1999 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 5, 1999 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 3, 1999 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 19, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 4, 1999 | CNEA | F | EXAMINER'S AMENDMENT MAILED | Loading... |
| May 28, 1999 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely, potassium magnesium citrate wax matrix tablets, used to replenish potassium and magnesium electrolytes for patients taking diuretics
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005